Macquarie Group Ltd. decreased its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 1.2% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 69,460 shares of the company’s stock after selling 838 shares during the quarter. Macquarie Group Ltd.’s holdings in Ryan Specialty were worth $2,795,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of RYAN. Royal Bank of Canada grew its stake in shares of Ryan Specialty by 524.8% in the 1st quarter. Royal Bank of Canada now owns 781 shares of the company’s stock worth $31,000 after buying an additional 656 shares in the last quarter. BOKF NA purchased a new position in shares of Ryan Specialty in the 1st quarter worth $49,000. American International Group Inc. purchased a new position in shares of Ryan Specialty in the 2nd quarter worth $50,000. Quantbot Technologies LP purchased a new position in shares of Ryan Specialty in the 2nd quarter worth $51,000. Finally, Federated Hermes Inc. purchased a new position in shares of Ryan Specialty in the 3rd quarter worth $53,000. Institutional investors own 34.09% of the company’s stock.
Ryan Specialty Trading Up 0.3 %
Shares of RYAN opened at $49.27 on Tuesday. Ryan Specialty Holdings, Inc. has a 1-year low of $32.13 and a 1-year high of $49.77. The company has a 50-day moving average of $46.09 and a 200 day moving average of $43.08. The firm has a market capitalization of $12.82 billion, a price-to-earnings ratio of 82.12 and a beta of 0.42. The company has a debt-to-equity ratio of 2.06, a current ratio of 1.22 and a quick ratio of 1.22.
In other news, Director Nicholas Dominic Cortezi sold 25,000 shares of the business’s stock in a transaction dated Thursday, June 29th. The shares were sold at an average price of $44.05, for a total value of $1,101,250.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, insider Lisa Jo Paschal-Alcorn sold 2,202 shares of Ryan Specialty stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $45.00, for a total value of $99,090.00. Following the transaction, the insider now owns 46,422 shares of the company’s stock, valued at approximately $2,088,990. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Nicholas Dominic Cortezi sold 25,000 shares of Ryan Specialty stock in a transaction that occurred on Thursday, June 29th. The stock was sold at an average price of $44.05, for a total transaction of $1,101,250.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 543,132 shares of company stock worth $24,220,125. 54.51% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on RYAN shares. Barclays lifted their price target on shares of Ryan Specialty from $51.00 to $52.00 and gave the stock an “overweight” rating in a research note on Friday, August 4th. JPMorgan Chase & Co. lifted their price target on shares of Ryan Specialty from $39.00 to $43.00 in a research note on Thursday, July 6th. Finally, Wells Fargo & Company lifted their price target on shares of Ryan Specialty from $50.00 to $53.00 and gave the stock an “overweight” rating in a research note on Friday, August 4th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Ryan Specialty currently has a consensus rating of “Hold” and a consensus target price of $48.29.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
- Five stocks we like better than Ryan Specialty
- What Are Dividend Champions? How to Invest in the Champions
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- Mega Cap Stocks: What They Are and How to Invest
- 5 Reasons Mullen Automotive is About to Turn a Corner
- Dividend Tax Calculator
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.